CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER Drug Patent Profile

When do Cardene In 0.83% Sodium Chloride In Plastic Container patents expire, and when can generic versions of Cardene In 0.83% Sodium Chloride In Plastic Container launch?

Cardene In 0.83% Sodium Chloride In Plastic Container is a drug marketed by Chiesi and is included in one NDA. There are six patents protecting this drug.

This drug has twenty-one patent family members in ten countries.

The generic ingredient in CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER is nicardipine hydrochloride. There are eleven drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the nicardipine hydrochloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Cardene In 0.83% Sodium Chloride In Plastic Container

A generic version of CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER was approved as nicardipine hydrochloride by ANI PHARMS on October 28^th, 1996.

Summary for CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER

International Patents:	21
US Patents:	6
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	2
Raw Ingredient (Bulk) Api Vendors:	55
Clinical Trials:	9
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER
DailyMed Link:	CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER at DailyMed

Recent Clinical Trials for CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Boston Medical Center	Phase 4
University of Cincinnati	Phase 2
Vanderbilt University Medical Center	Phase 2

See all CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER clinical trials

Pharmacology for CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER

Drug Class	Dihydropyridine Calcium Channel Blocker
Mechanism of Action	Calcium Channel Antagonists Cytochrome P450 2C19 Inhibitors Cytochrome P450 2C8 Inhibitors Cytochrome P450 2D6 Inhibitors Cytochrome P450 3A4 Inhibitors

US Patents and Regulatory Information for CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER

CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER is protected by six US patents.

Patents protecting CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Chiesi	CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER	nicardipine hydrochloride	INJECTABLE;INTRAVENOUS	019734-004	Nov 7, 2008	AP	RX	Yes	Yes
Chiesi	CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER	nicardipine hydrochloride	INJECTABLE;INTRAVENOUS	019734-004	Nov 7, 2008	AP	RX	Yes	Yes			Y
Chiesi	CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER	nicardipine hydrochloride	INJECTABLE;INTRAVENOUS	019734-004	Nov 7, 2008	AP	RX	Yes	Yes

International Patents for CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER

See the table below for patents covering CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER around the world.

Country	Patent Number	Title	Estimated Expiration
Canada	2649779	COMPOSITIONS EN BOLUS IV PRE-MELANGEES PRETES A L'EMPLOI ET PROCEDES D'UTILISATION (PRE-MIXED, READY-TO-USE IV BOLUS COMPOSITIONS AND METHODS OFUSE)
Japan	S5545075
Mexico	9203588	INYECCION DE HIDROCLORURO DE NICARDIPINA.